Finland
Blueprint Genetics is a genetic diagnostics company founded in 2012 and headquartered in Finland. Specializing in biotechnology and healthcare, the company offers world-class genetic diagnostics and clinical interpretation for inherited diseases. With a global team representing more than 20 nationalities and a diverse range of expertise, including geneticists, data analysts, laboratory technicians, client service specialists, genetic services consultants, software developers, and marketing specialists, Blueprint Genetics is at the forefront of genetic knowledge and AI within the life sciences industry.
Having received a Debt Financing investment from Bootstrap Europe on 07 September 2020, Blueprint Genetics is committed to pushing genetic knowledge into the mainstream, working with customers in over 70 countries to facilitate easier access to genetic information for the medical community. The company's comprehensive and cost-effective genetic tests play a crucial role in supporting healthcare professionals worldwide, enabling them to provide the best care for patients and families affected by rare inherited diseases.
